Step into the cutting-edge world of high-throughput screening (HTS) with Jose Castro-Perez, Vice President of Product Management at SCIEX. In this exclusive interview, Castro-Perez unveils the groundbreaking Echo® MS+ system launched at SLAS 2024, showcasing its potential to transform HTS. With over 25 years of experience in LC/MS-MS and bioanalysis, Castro-Perez shares insights on how this innovative technology, powered by Acoustic Ejection Mass Spectrometry (AEMS), is reshaping hit identification, lead optimisation, and drug discovery timelines.
Key Concepts:
- Introduction to Jose Castro-Perez and his journey in the life sciences sector
- Unveiling the Echo® MS+ system: AEMS technology and expanded screening workflows
- Differentiation factors: high-quality data, precision, speed, label-free measurement, and versatility
- Addressing unmet analytical needs and system versatility for multiple workflows
- Accelerating hit identification and lead optimisation with Echo® MS+ and its impact on reducing time and costs
- Collaboration with customers and overcoming challenges in system development
- Cultivating a culture of innovation at SCIEX and key factors for successful product launches
- Future innovations and trends in mass spectrometry and SCIEX’s roadmap
How do you envision the integration of cutting-edge technologies like the Echo® MS+ system reshaping the landscape of drug discovery and development in the next decade?